Skip to main content
. 2014 Nov 17;54(3):383–391. doi: 10.1093/rheumatology/keu429

Table 1.

Some of the indications for the use of IVIG in the rheumatic diseases

Red (high priority)
    Kawasaki disease
    Chronic inflammatory demyelinating polyneuropathy
    Guillain–Barré syndrome
Blue (medium priority)
    Inflammatory myopathies
    Congenital heart block
    Autoimmune haemolytic anaemia
Grey (low priority)
    SLE without secondary immunocytopenias
    Stroke with APS
    Catastrophic APS
    Systemic vasculitides and ANCA disorders
    CNS vasculitis
    Systemic JIA
    Complex regional pain syndrome
Black (no indication)
    RA
    Chronic fatigue syndrome